Новини фондового ринку
Останні фінансові новини · Оновлено Лип 26, 2026
Uniti Group Inc. Звіт про прибутки за 1 квартал 2026 року
Uniti Group Inc. Q1 2026 Earnings Call Summary
Panelists agree on Uniti's (UNIT) ambitious fiber expansion plan, but disagree on its feasibility and risk profile. Gemini and Grok …
Village Farms International, Inc. Звіт про прибутки за 1 квартал 2026 року
Village Farms International, Inc. Q1 2026 Earnings Call Summary
Panelists agree that Village Farms (VFF) has successfully transitioned to a high-margin cannabis exporter, with robust international traction and a …
Мої 2 найкращі нещодавні технологічні IPO для купівлі на травень 2026 року
My Top 2 Recent Tech IPOs to Buy for May 2026
The panel consensus is bearish on both Circle (CRCL) and CoreWeave (CRWV), citing existential regulatory risks, reliance on a few …
Galaxy-Backed Boundary запустить стейблкоїн USBD
Galaxy-Backed Boundary To Launch USBD Stablecoin
Despite the potential of daily on-chain verification, Boundary Labs' USBD stablecoin faces significant challenges in liquidity, regulatory compliance, and operational …
Radiant Logistics перевищує очікування FQ3
Radiant Logistics beats FQ3 expectations
Despite a clean EPS beat, Radiant Logistics' (RLGT) operational margins eroded significantly, and international headwinds pose substantial risks to its …
Інвестор «Великої гри на пониження» Майкл Беррі каже, що ринок «перетнув межу» — що, на його думку, інвестори роблять неправильно
'Big Short' investor Michael Burry says the market has 'jumped the shark' — what he says investors are getting wrong
Panelists agree that while the current market has notable concentration risk and high valuations, it may persist due to structural …
Chardan знижує цільову ціну для Iovance (IOVA), зберігає рейтинг «Купувати»
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
While IOVA's Q1 revenue growth is impressive, the panelists have mixed views on its sustainability and profitability. The price target …
Canaccord зберігає рейтинг "Купити" для Taysha (TSHA) після ключових моментів 1 кварталу
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights
The panelists have mixed views on TSHA's potential. While some see promise in the FDA alignment and the addressable market, …
H.C. Wainwright та Wells Fargo підвищили цільову ціну MannKind (MNKD)
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
The panelists agree that MannKind's (MNKD) valuation hinges on the success of its royalty streams, particularly from Tyvaso DPI, and …
1 Топ аналітик з Wall Street вважає, що CRISPR Therapeutics може більше ніж подвоїтися. Чи варто купувати акції з усією завзятістю?
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
CRISPR Therapeutics' stock performance is driven by optimism around CTX611 and oncology candidates, but faces significant risks including complex manufacturing, …
Чи Geron (GERN) є однією з найкращих акцій США вартістю до 5 доларів США, які варто купити?
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
Geron's (GERN) commercial success hinges on RYTELO's adoption curve and potential label expansion. While Q1 2026 revenue of $51.8M shows …
Зростання прибутку Korea Electric Power у 1 кварталі
Korea Electric Power Q1 Earnings Rise
The panel consensus is bearish, with all participants expressing concerns about KEP's earnings growth, margin compression, and significant debt servicing …